Form 13-F position report

IMMUNIC INC COM (DE)

Reported by PURA VIDA INVESTMENTS LLC

IMUX CUSIP 4525EP101 Manager CIK 0001590144

First reported at 683,287 shares this quarter.

New
% of reported 13F value 0.25% This manager · Q1 2022
Shares 683,287 Quarter-end amount reported
Reported value $7,721,000 Fair value at quarter end
Consecutive quarters held 1 Through Q1 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 7721000
2022-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for IMMUNIC INC COM (DE) held by PURA VIDA INVESTMENTS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2022 Reduced 0 -683,287 (-100.0%) 0 $0 2022-08-15
Q1 2022 New 683,287 +683,287 (0.0%) 0.25% $7,721,000 2022-05-16

Who else reported the position

87 managers reported IMMUNIC INC COM (DE) for Q1 2022.

Managers reporting IMMUNIC INC COM (DE) in Q1 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RTW INVESTMENTS LP Added 2,705,513 +990,043 0.63% $30,572,000 7 qtrs
Omega Fund Management LLC Unchanged 1,788,160 0 4.14% $20,206,000 12 qtrs
BlackRock Inc Added 1,314,484 +11,708 < 0.01% $14,853,000 12 qtrs
COWEN AND COMPANY LLC Added 1,257,146 +1,001,291 1.37% $14,206,000 2 qtrs
Parkman Healthcare Partners LLC Added 1,089,251 +115,068 3.6% $12,309,000 8 qtrs
VANGUARD GROUP INC Added 956,697 +54,867 < 0.01% $10,811,000 12 qtrs
COMMODORE CAPITAL LP New 893,013 +893,013 2.25% $10,091,000 1 qtr
Point72 Asset Management L P Unchanged 725,000 0 0.03% $8,193,000 8 qtrs
Artal Group S A Unchanged 700,000 0 0.33% $7,910,000 10 qtrs
PURA VIDA INVESTMENTS LLC This report New 683,287 +683,287 0.25% $7,721,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2022
Filed
May 16, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
683,287
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.